Back to Search
Start Over
Influence of T Cell-Mediated Immune Surveillance on Somatic Mutation Occurrences in Melanoma.
- Source :
-
Frontiers in immunology [Front Immunol] 2022 Jan 17; Vol. 12, pp. 703821. Date of Electronic Publication: 2022 Jan 17 (Print Publication: 2021). - Publication Year :
- 2022
-
Abstract
- Background: Neoantigens are presented on the cancer cell surface by peptide-restricted human leukocyte antigen (HLA) proteins and can subsequently activate cognate T cells. It has been hypothesized that the observed somatic mutations in tumors are shaped by immunosurveillance.<br />Methods: We investigated all somatic mutations identified in The Cancer Genome Atlas (TCGA) Skin Cutaneous Melanoma (SKCM) samples. By applying a computational algorithm, we calculated the binding affinity of the resulting neo-peptides and their corresponding wild-type peptides with the major histocompatibility complex (MHC) Class I complex. We then examined the relationship between binding affinity alterations and mutation frequency.<br />Results: Our results show that neoantigens derived from recurrent mutations tend to have lower binding affinities with the MHC Class I complex compared to peptides from non-recurrent mutations. Tumor samples harboring recurrent SKCM mutations exhibited lower immune infiltration levels, indicating a relatively colder immune microenvironment.<br />Conclusions: These results suggested that the occurrences of somatic mutations in melanoma have been shaped by immunosurveillance. Mutations that lead to neoantigens with high MHC class I binding affinity are more likely to be eliminated and thus are less likely to be present in tumors.<br />Competing Interests: Author C-CC was employed by the company Chempartner Corporation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Jiang, Schaafsma, Hong, Zhao, Zhu, Chao and Cheng.)
- Subjects :
- Antigens, Neoplasm immunology
Histocompatibility Antigens Class I immunology
Humans
Immunotherapy methods
Mutation Rate
Peptides immunology
Tumor Microenvironment immunology
Melanoma, Cutaneous Malignant
Immunologic Surveillance immunology
Melanoma immunology
Mutation immunology
Skin Neoplasms immunology
T-Lymphocytes immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 35111147
- Full Text :
- https://doi.org/10.3389/fimmu.2021.703821